Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00004904
What this trial is testing

Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Northwestern University
Early research (Phase 1)Study completedNCT00780104
What this trial is testing

Sirolimus in Combination With MEC in High Risk Myeloid Leukemias

Who this might be right for
Myeloid LeukemiasAMLLeukemia+1 more
Abramson Cancer Center at Penn Medicine 16
Testing effectiveness (Phase 2)Study completedNCT01682226
What this trial is testing

Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
LeukemiaMyelodysplastic SyndromeLymphoma
Memorial Sloan Kettering Cancer Center 84
Large-scale testing (Phase 3)Study completedNCT00205764
What this trial is testing

Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy

Who this might be right for
Multiple Myeloma
Austrian Forum Against Cancer 212
Early research (Phase 1)Ended earlyNCT00852709
What this trial is testing

Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid LeukemiaMyeloproliferative Disorders+7 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Testing effectiveness (Phase 2)Study completedNCT01314014
What this trial is testing

Imexon for Relapsed Follicular and Aggressive Lymphomas

Who this might be right for
Follicular LymphomaSmall Lymphocytic LymphomaMarginal Zone Lymphoma+4 more
University of Rochester 22
Large-scale testing (Phase 3)Study completedNCT01802333
What this trial is testing

Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaUntreated Adult Acute Myeloid Leukemia
National Cancer Institute (NCI) 754
Testing effectiveness (Phase 2)Active Not RecruitingNCT05583552
What this trial is testing

Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
GCP-Service International West GmbH 46
Large-scale testing (Phase 3)Study completedNCT02288741
What this trial is testing

Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy

Who this might be right for
Multiple Myeloma
WiSP Wissenschaftlicher Service Pharma GmbH 549
Testing effectiveness (Phase 2)Ended earlyNCT00776373
What this trial is testing

Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies

Who this might be right for
ALLBurkitt's LymphomaLymphoblastic Leukemia+1 more
Abramson Cancer Center at Penn Medicine 4
Early research (Phase 1)Active Not RecruitingNCT03549442
What this trial is testing

Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 40
Post-approval studies (Phase 4)Study completedNCT04948463
What this trial is testing

Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia

Who this might be right for
Febrile Neutropenia
Murdoch Childrens Research Institute 55
Testing effectiveness (Phase 2)Looking for participantsNCT04644016
What this trial is testing

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Who this might be right for
AMLALLMDS+6 more
Memorial Sloan Kettering Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT01200485
What this trial is testing

Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 55
Not applicableStudy completedNCT05238376
What this trial is testing

Survivorship Post-HCT Optimization Program

Who this might be right for
Hematologic Malignancy
Duke University 16
Large-scale testing (Phase 3)Study completedNCT00381680
What this trial is testing

Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
B-cell Childhood Acute Lymphoblastic LeukemiaL1 Childhood Acute Lymphoblastic LeukemiaL2 Childhood Acute Lymphoblastic Leukemia+1 more
Children's Oncology Group 275
Testing effectiveness (Phase 2)Study completedNCT00335647
What this trial is testing

Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Immune Control 30
Testing effectiveness (Phase 2)Study completedNCT00656617
What this trial is testing

Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
M.D. Anderson Cancer Center 106
Early research (Phase 1)Study completedNCT03600155
What this trial is testing

Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia+1 more
M.D. Anderson Cancer Center 29
Not applicableUnknownNCT05473325
What this trial is testing

Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)

Who this might be right for
DiabetesChronic Kidney DiseasesCancer+25 more
Willows Health 2,000
Next Page